These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 32900259)

  • 1. Neurobiological mechanisms associated with antipsychotic drug-induced dystonia.
    Loonen AJ; Ivanova SA
    J Psychopharmacol; 2021 Jan; 35(1):3-14. PubMed ID: 32900259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Striatal cholinergic interneurons and D2 receptor-expressing GABAergic medium spiny neurons regulate tardive dyskinesia.
    Bordia T; Zhang D; Perez XA; Quik M
    Exp Neurol; 2016 Dec; 286():32-39. PubMed ID: 27658674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinsonism Driven by Antipsychotics Originates from Dopaminergic Control of Striatal Cholinergic Interneurons.
    Kharkwal G; Brami-Cherrier K; Lizardi-Ortiz JE; Nelson AB; Ramos M; Del Barrio D; Sulzer D; Kreitzer AC; Borrelli E
    Neuron; 2016 Jul; 91(1):67-78. PubMed ID: 27387649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of severe axial tardive dystonia with clozapine: case report and hypothesis.
    Trugman JM; Leadbetter R; Zalis ME; Burgdorf RO; Wooten GF
    Mov Disord; 1994 Jul; 9(4):441-6. PubMed ID: 7969212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strength of cholinergic tone dictates the polarity of dopamine D2 receptor modulation of striatal cholinergic interneuron excitability in DYT1 dystonia.
    Scarduzio M; Zimmerman CN; Jaunarajs KL; Wang Q; Standaert DG; McMahon LL
    Exp Neurol; 2017 Sep; 295():162-175. PubMed ID: 28587876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced Pisa syndrome (pleurothotonus): epidemiology and management.
    Suzuki T; Matsuzaka H
    CNS Drugs; 2002; 16(3):165-74. PubMed ID: 11888337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diverse Mechanisms Lead to Common Dysfunction of Striatal Cholinergic Interneurons in Distinct Genetic Mouse Models of Dystonia.
    Eskow Jaunarajs KL; Scarduzio M; Ehrlich ME; McMahon LL; Standaert DG
    J Neurosci; 2019 Sep; 39(36):7195-7205. PubMed ID: 31320448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology of antipsychotic drug-induced movement disorders.
    Casey DE
    J Clin Psychiatry; 2004; 65 Suppl 9():25-8. PubMed ID: 15189109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulpiride-induced tardive dystonia.
    Miller LG; Jankovic J
    Mov Disord; 1990; 5(1):83-4. PubMed ID: 1967484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing antipsychotic-induced acute and tardive dystonia.
    Raja M
    Drug Saf; 1998 Jul; 19(1):57-72. PubMed ID: 9673858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response--a double-blind PET study in schizophrenia.
    Agid O; Mamo D; Ginovart N; Vitcu I; Wilson AA; Zipursky RB; Kapur S
    Neuropsychopharmacology; 2007 Jun; 32(6):1209-15. PubMed ID: 17077809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased number of striatal cholinergic interneurons and motor deficits in dopamine receptor 2-expressing-cell-specific Dyt1 conditional knockout mice.
    Yokoi F; Oleas J; Xing H; Liu Y; Dexter KM; Misztal C; Gerard M; Efimenko I; Lynch P; Villanueva M; Alsina R; Krishnaswamy S; Vaillancourt DE; Li Y
    Neurobiol Dis; 2020 Feb; 134():104638. PubMed ID: 31618684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of combined L-dopa and central anticholinergic in a patient with severe drug-induced parkinsonism and tardive dystonia.
    Looper KJ; Chouinard G
    Can J Psychiatry; 1998 Aug; 43(6):646-7. PubMed ID: 9729698
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of several partial dopamine D2 receptor agonists in Cebus apella monkeys previously treated with haloperidol.
    Peacock L; Gerlach J
    Eur J Pharmacol; 1993 Jun; 237(2-3):329-40. PubMed ID: 8103465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative allosteric modulation of mGlu5 receptor rescues striatal D2 dopamine receptor dysfunction in rodent models of DYT1 dystonia.
    Sciamanna G; Ponterio G; Tassone A; Maltese M; Madeo G; Martella G; Poli S; Schirinzi T; Bonsi P; Pisani A
    Neuropharmacology; 2014 Oct; 85():440-50. PubMed ID: 24951854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal basis of neuroleptic-induced extrapyramidal side effects.
    Ossowska K
    Pol J Pharmacol; 2002; 54(4):299-312. PubMed ID: 12523484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striatal parvalbumin interneurons are activated in a mouse model of cerebellar dystonia.
    Matsuda T; Morigaki R; Hayasawa H; Koyama H; Oda T; Miyake K; Takagi Y
    Dis Model Mech; 2024 May; 17(5):. PubMed ID: 38616770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic Control of Striatal Cholinergic Interneurons Underlies Cocaine-Induced Psychostimulation.
    Lewis RG; Serra M; Radl D; Gori M; Tran C; Michalak SE; Vanderwal CD; Borrelli E
    Cell Rep; 2020 Apr; 31(3):107527. PubMed ID: 32320647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors.
    Seeman P; Tallerico T
    Mol Psychiatry; 1998 Mar; 3(2):123-34. PubMed ID: 9577836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chronic administration of neuroleptic and anticholinergic agents on densities of D2 dopamine and muscarinic cholinergic receptors in rat striatum.
    Boyson SJ; McGonigle P; Luthin GR; Wolfe BB; Molinoff PB
    J Pharmacol Exp Ther; 1988 Mar; 244(3):987-93. PubMed ID: 2908050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.